Emerald Mutual Fund Advisers Trust’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.3M | Sell |
550,634
-23,446
| -4% | -$693K | 0.99% | 34 |
|
|
2025
Q1 | $17.1M | Buy |
574,080
+4,513
| +0.8% | +$135K | 1.22% | 29 |
|
|
2024
Q4 | $16.3M | Sell |
569,567
-92,724
| -14% | -$2.66M | 0.99% | 40 |
|
|
2024
Q3 | $25.6M | Buy |
662,291
+131,835
| +25% | +$5.09M | 1.33% | 21 |
|
|
2024
Q2 | $17.1M | Buy |
530,456
+19,255
| +4% | +$620K | 0.89% | 45 |
|
|
2024
Q1 | $19.8M | Sell |
511,201
-40,593
| -7% | -$1.58M | 1.03% | 36 |
|
|
2023
Q4 | $17M | Sell |
551,794
-7,686
| -1% | -$237K | 0.9% | 42 |
|
|
2023
Q3 | $12.5M | Sell |
559,480
-117,680
| -17% | -$2.63M | 0.75% | 58 |
|
|
2023
Q2 | $14.6M | Hold |
677,160
| – | – | 0.79% | 62 |
|
|
2023
Q1 | $16.2M | Sell |
677,160
-8,733
| -1% | -$210K | 0.96% | 38 |
|
|
2022
Q4 | $15.9M | Sell |
685,893
-9,500
| -1% | -$220K | 0.99% | 42 |
|
|
2022
Q3 | $11.1M | Sell |
695,393
-12,446
| -2% | -$199K | 0.7% | 59 |
|
|
2022
Q2 | $12.5M | Buy |
707,839
+39,160
| +6% | +$694K | 0.73% | 57 |
|
|
2022
Q1 | $13.6M | Buy |
668,679
+18,281
| +3% | +$372K | 0.6% | 65 |
|
|
2021
Q4 | $12.1M | Sell |
650,398
-60,000
| -8% | -$1.12M | 0.43% | 81 |
|
|
2021
Q3 | $14M | Sell |
710,398
-79,993
| -10% | -$1.58M | 0.49% | 74 |
|
|
2021
Q2 | $18.7M | Hold |
790,391
| – | – | 0.61% | 68 |
|
|
2021
Q1 | $18.7M | Buy |
790,391
+2,362
| +0.3% | +$56K | 0.62% | 75 |
|
|
2020
Q4 | $15.8M | Buy |
788,029
+140,700
| +22% | +$2.82M | 0.55% | 79 |
|
|
2020
Q3 | $13.5M | Buy |
647,329
+123,066
| +23% | +$2.56M | 0.6% | 67 |
|
|
2020
Q2 | $9.18M | Sell |
524,263
-147,032
| -22% | -$2.57M | 0.43% | 80 |
|
|
2020
Q1 | $11M | Sell |
671,295
-93,617
| -12% | -$1.53M | 0.69% | 53 |
|
|
2019
Q4 | $15.7M | Buy |
+764,912
| New | +$15.7M | 0.64% | 54 |
|